ArticleAME case reports2025
Isolated pulmonary metastasis occurring 10 years after total thyroidectomy and lymphadenectomy of a papillary thyroid carcinoma: a rare case report.
Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary thyroid carcinoma (PTC) is the most common types of thyroid cancer; and the 10-year survival rate vary from 85% to 100%. Although the prognosis of PTC is generally favorable, recurrence and metastasis occur in approximately 4.3% to 35% of cases. Lymph node metastasis is relatively prevalent, while distant metastasis is comparatively infrequent. Case Description: This case report details a 61-year-old female diagnosed with PTC. The patient's pathological stage was pT3aN1aM0, and according to the American Thyroid Association (ATA) risk classification, she was categorized as intermediate risk. The patient underwent total thyroidectomy and local lymph node dissection; however, radioactive iodine-131 treatment was not administered. Postoperatively, the patient regularly consumed levothyroxine sodium yet failed to have her thyroid hormone levels monitored. A decade following the surgical procedure, the patient presented with isolated lung metastasis. However, given the lengthy history of the patient's thyroid cancer, the clinical diagnosis initially entertained the possibility of a primary lung tumor. Subsequently, a wedge resection of the lung was performed on the patient, and the postoperative pathology confirmed metastasis of PTC. Conclusions: This rare case appears to indicate that patients with intermediate-risk PTC, as defined by the ATA, may benefit from postoperative radioactive iodine-131 treatment. Such treatment could potentially minimize the likelihood of tumor recurrence and metastasis to the greatest possible extent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.